{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:11:53Z","timestamp":1776669113633,"version":"3.51.2"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"science and technology research program of Chongqing Municipal Education Commission","award":["KJQN202402830"],"award-info":[{"award-number":["KJQN202402830"]}]},{"name":"Chongqing postdoctoral completion and retention funding program","award":["ygzbhly2025103"],"award-info":[{"award-number":["ygzbhly2025103"]}]},{"name":"school-level project fund of Chongqing Medical and Pharmaceutical College","award":["YGZZKRC2025107"],"award-info":[{"award-number":["YGZZKRC2025107"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-42801-8","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:24:51Z","timestamp":1773087891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CD47 as a prognostic biomarker and potential immunotherapy target in penile squamous cell carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Junying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xugang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangkun","family":"Ao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaolei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihua","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"42801_CR1","doi-asserted-by":"publisher","unstructured":"Brouwer, O. R. et al. European association of urology-American society of clinical oncology collaborative guideline on penile cancer: 2023 update. Eur. Urol. 83, 548\u2013560. https:\/\/doi.org\/10.1016\/j.eururo.2023.02.027 (2023).","DOI":"10.1016\/j.eururo.2023.02.027"},{"key":"42801_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/mou.0000000000000581","volume":"29","author":"A Douglawi","year":"2019","unstructured":"Douglawi, A. & Masterson, T. A. Penile cancer epidemiology and risk factors: a contemporary review. Curr. Opin. Urol. 29, 145\u2013149. https:\/\/doi.org\/10.1097\/mou.0000000000000581 (2019).","journal-title":"Curr. Opin. Urol."},{"key":"42801_CR3","doi-asserted-by":"publisher","unstructured":"Thomas, A. et al. Penile cancer. Nat. Rev. Dis. Primers. 7 https:\/\/doi.org\/10.1038\/s41572-021-00246-5 (2021).","DOI":"10.1038\/s41572-021-00246-5"},{"key":"42801_CR4","doi-asserted-by":"publisher","unstructured":"Ahmed, M. E., Falasiri, S., Hajiran, A., Chahoud, J. & Spiess, P. E. The Immune Microenvironment in penile cancer and rationale for immunotherapy. J. Clin. Med. 9 https:\/\/doi.org\/10.3390\/jcm9103334 (2020).","DOI":"10.3390\/jcm9103334"},{"key":"42801_CR5","doi-asserted-by":"publisher","first-page":"1055235","DOI":"10.3389\/fimmu.2022.1055235","volume":"13","author":"Y Tang","year":"2022","unstructured":"Tang, Y., Hu, X., Wu, K. & Li, X. Immune landscape and immunotherapy for penile cancer. Front. Immunol. 13, 1055235. https:\/\/doi.org\/10.3389\/fimmu.2022.1055235 (2022).","journal-title":"Front. Immunol."},{"key":"42801_CR6","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1093\/jnci\/djad155","volume":"115","author":"T El Zarif","year":"2023","unstructured":"El Zarif, T. et al. Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors. J. Natl Cancer Inst. 115, 1605\u20131615. https:\/\/doi.org\/10.1093\/jnci\/djad155 (2023).","journal-title":"J. Natl Cancer Inst."},{"key":"42801_CR7","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1200\/jco.22.02894","volume":"41","author":"HM de Vries","year":"2023","unstructured":"de Vries, H. M. et al. Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial. J. Clin. oncology: official J. Am. Soc. Clin. Oncol. 41, 4872\u20134880. https:\/\/doi.org\/10.1200\/jco.22.02894 (2023).","journal-title":"J. Clin. oncology: official J. Am. Soc. Clin. Oncol."},{"key":"42801_CR8","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","volume":"52","author":"MEW Logtenberg","year":"2020","unstructured":"Logtenberg, M. E. W., Scheeren, F. A. & Schumacher, T. N. The CD47-SIRP\u03b1 Immune Checkpoint. Immunity 52, 742\u2013752. https:\/\/doi.org\/10.1016\/j.immuni.2020.04.011 (2020).","journal-title":"Immunity"},{"key":"42801_CR9","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.7150\/thno.40860","volume":"10","author":"T Hu","year":"2020","unstructured":"Hu, T. et al. Tumor-intrinsic CD47 signal regulates glycolysis and promotes colorectal cancer cell growth and metastasis. Theranostics 10, 4056\u20134072. https:\/\/doi.org\/10.7150\/thno.40860 (2020).","journal-title":"Theranostics"},{"key":"42801_CR10","doi-asserted-by":"publisher","unstructured":"Jiang, W. et al. Immune inactivation by CD47 expression predicts clinical outcomes and therapeutic responses in clear cell renal cell carcinoma patients. Urol. Oncol. 40 https:\/\/doi.org\/10.1016\/j.urolonc.2021.11.024 (2022). 166.e115-166.e125.","DOI":"10.1016\/j.urolonc.2021.11.024"},{"key":"42801_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/jclinpath-2020-206611","volume":"74","author":"H Kim","year":"2021","unstructured":"Kim, H., Bang, S., Jee, S., Paik, S. S. & Jang, K. Clinicopathological significance of CD47 expression in hepatocellular carcinoma. J. Clin. Pathol. 74, 111\u2013115. https:\/\/doi.org\/10.1136\/jclinpath-2020-206611 (2021).","journal-title":"J. Clin. Pathol."},{"key":"42801_CR12","first-page":"2901","volume":"9","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Overexpression of CD47 predicts poor prognosis and promotes cancer cell invasion in high-grade serous ovarian carcinoma. Am. J. translational Res. 9, 2901\u20132910 (2017).","journal-title":"Am. J. translational Res."},{"key":"42801_CR13","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s00262-020-02806-2","volume":"70","author":"M Shi","year":"2021","unstructured":"Shi, M. et al. CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration. Cancer Immunol. immunotherapy: CII. 70, 1831\u20131840. https:\/\/doi.org\/10.1007\/s00262-020-02806-2 (2021).","journal-title":"Cancer Immunol. immunotherapy: CII"},{"key":"42801_CR14","doi-asserted-by":"publisher","unstructured":"Wang, H. et al. CD47\/SIRP\u03b1 blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy. J. Immunother. Cancer. 8 https:\/\/doi.org\/10.1136\/jitc-2020-000905 (2020).","DOI":"10.1136\/jitc-2020-000905"},{"key":"42801_CR15","doi-asserted-by":"publisher","unstructured":"Chen, S. H. et al. Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity. J. Immunother. Cancer. 9 https:\/\/doi.org\/10.1136\/jitc-2021-003464 (2021).","DOI":"10.1136\/jitc-2021-003464"},{"key":"42801_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13045-019-0822-6","volume":"12","author":"Y Pan","year":"2019","unstructured":"Pan, Y. et al. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer. J. Hematol. Oncol. 12, 124. https:\/\/doi.org\/10.1186\/s13045-019-0822-6 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"42801_CR17","doi-asserted-by":"publisher","unstructured":"Jiang, C. et al. Targeting the CD47\/SIRP\u03b1 pathway in malignancies: recent progress, difficulties and future perspectives. Front. Oncol. 14 https:\/\/doi.org\/10.3389\/fonc.2024.1378647 (2024).","DOI":"10.3389\/fonc.2024.1378647"},{"key":"42801_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12935-019-0957-0","volume":"19","author":"J Yuan","year":"2019","unstructured":"Yuan, J. et al. Combined high expression of CD47 and CD68 is a novel prognostic factor for breast cancer patients. Cancer Cell Int. 19, 238. https:\/\/doi.org\/10.1186\/s12935-019-0957-0 (2019).","journal-title":"Cancer Cell Int."},{"key":"42801_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41419-021-03556-4","volume":"12","author":"S Xu","year":"2021","unstructured":"Xu, S., Wang, X., Yang, Y., Li, Y. & Wu, S. LSD1 silencing contributes to enhanced efficacy of anti-CD47\/PD-L1 immunotherapy in cervical cancer. Cell Death Dis. 12, 282. https:\/\/doi.org\/10.1038\/s41419-021-03556-4 (2021).","journal-title":"Cell Death Dis."},{"key":"42801_CR20","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.3892\/mmr.2015.4037","volume":"12","author":"BL Ma","year":"2015","unstructured":"Ma, B. L. et al. Immunohistochemical analysis of phosphorylated mammalian target of rapamycin and its downstream signaling components in invasive breast cancer. Mol. Med. Rep. 12, 5246\u20135254. https:\/\/doi.org\/10.3892\/mmr.2015.4037 (2015).","journal-title":"Mol. Med. Rep."},{"key":"42801_CR21","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk, D. et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43, D447\u2013452. https:\/\/doi.org\/10.1093\/nar\/gku1003 (2015).","journal-title":"Nucleic Acids Res."},{"key":"42801_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen, B., Khodadoust, M. S., Liu, C. L., Newman, A. M. & Alizadeh, A. A. Profiling Tumor Infiltrating Immune Cells with CIBERSORT. Methods Mol. biology (Clifton N J). 1711, 243\u2013259. https:\/\/doi.org\/10.1007\/978-1-4939-7493-1_12 (2018).","journal-title":"Methods Mol. biology (Clifton N J)"},{"key":"42801_CR23","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612. https:\/\/doi.org\/10.1038\/ncomms3612 (2013).","journal-title":"Nat. Commun."},{"key":"42801_CR24","doi-asserted-by":"publisher","unstructured":"Zeng, D. et al. Enhancing immuno-oncology investigations through multidimensional decoding of tumor microenvironment with IOBR 2.0. Cell. Rep. methods. 4 https:\/\/doi.org\/10.1016\/j.crmeth.2024.100910 (2024).","DOI":"10.1016\/j.crmeth.2024.100910"},{"key":"42801_CR25","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Ishiguro-Watanabe, M. & Tanabe, M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 49, D545\u2013d551. https:\/\/doi.org\/10.1093\/nar\/gkaa970 (2021).","journal-title":"Nucleic Acids Res."},{"key":"42801_CR26","doi-asserted-by":"publisher","unstructured":"Hu, F. F., Liu, C. J., Liu, L. L., Zhang, Q. & Guo, A. Y. Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response. Brief. Bioinform. 22 https:\/\/doi.org\/10.1093\/bib\/bbaa176 (2021).","DOI":"10.1093\/bib\/bbaa176"},{"key":"42801_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/cjp2.309","volume":"9","author":"Y Chen","year":"2023","unstructured":"Chen, Y., Klingen, T. A., Aas, H., Wik, E. & Akslen, L. A. CD47 and CD68 expression in breast cancer is associated with tumor-infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis. J. Pathol. Clin. Res. 9, 151\u2013164. https:\/\/doi.org\/10.1002\/cjp2.309 (2023).","journal-title":"J. Pathol. Clin. Res."},{"key":"42801_CR28","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.31557\/apjcp.2024.25.7.2515","volume":"25","author":"S Alhanafy","year":"2024","unstructured":"Alhanafy, S., Hany, H., Nasef, K., El-Salkh, I. & Elhawary, A. Immunohistochemical Expression of CD47 and CD68 in Breast Carcinoma and Their Prognostic Value. Asian Pac. J. cancer prevention: APJCP. 25, 2515\u20132527. https:\/\/doi.org\/10.31557\/apjcp.2024.25.7.2515 (2024).","journal-title":"Asian Pac. J. cancer prevention: APJCP"},{"key":"42801_CR29","doi-asserted-by":"publisher","first-page":"16609","DOI":"10.1007\/s00432-023-05408-4","volume":"149","author":"S Chen","year":"2023","unstructured":"Chen, S. et al. B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy. J. Cancer Res. Clin. Oncol. 149, 16609\u201316621. https:\/\/doi.org\/10.1007\/s00432-023-05408-4 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"42801_CR30","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1111\/1759-7714.13989","volume":"12","author":"Z Yang","year":"2021","unstructured":"Yang, Z. et al. PD-L1 and CD47 co-expression predicts survival and enlightens future dual-targeting immunotherapy in non-small cell lung cancer. Thorac. cancer. 12, 1743\u20131751. https:\/\/doi.org\/10.1111\/1759-7714.13989 (2021).","journal-title":"Thorac. cancer"},{"key":"42801_CR31","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.21037\/gs-24-400","volume":"13","author":"L Zhao","year":"2024","unstructured":"Zhao, L., Wang, X., Liu, H. & Lang, J. Chemotherapy-induced increase in CD47 expression in epithelial ovarian cancer. Gland Surg. 13, 1770\u20131784. https:\/\/doi.org\/10.21037\/gs-24-400 (2024).","journal-title":"Gland Surg."},{"key":"42801_CR32","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/cam4.1894","volume":"8","author":"JH Wang","year":"2019","unstructured":"Wang, J. H. et al. Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma. Cancer Med. 8, 1315\u20131325. https:\/\/doi.org\/10.1002\/cam4.1894 (2019).","journal-title":"Cancer Med."},{"key":"42801_CR33","doi-asserted-by":"publisher","first-page":"e1397248","DOI":"10.1080\/2162402x.2017.1397248","volume":"7","author":"L Wu","year":"2018","unstructured":"Wu, L. et al. Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma. Oncoimmunology 7, e1397248. https:\/\/doi.org\/10.1080\/2162402x.2017.1397248 (2018).","journal-title":"Oncoimmunology"},{"key":"42801_CR34","doi-asserted-by":"publisher","unstructured":"Pai, S. et al. CD47-SIRP\u03b1 Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma. Cells 8 https:\/\/doi.org\/10.3390\/cells8121658 (2019).","DOI":"10.3390\/cells8121658"},{"key":"42801_CR35","doi-asserted-by":"publisher","first-page":"e71443","DOI":"10.1002\/cam4.71443","volume":"14","author":"M Yu","year":"2025","unstructured":"Yu, M. et al. Overexpressed CD24 and CD47 Indicate a Worse Prognosis in Cervical Cancer. Cancer Med. 14, e71443. https:\/\/doi.org\/10.1002\/cam4.71443 (2025).","journal-title":"Cancer Med."},{"key":"42801_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1126\/science.aac9935","volume":"352","author":"SC Casey","year":"2016","unstructured":"Casey, S. C. et al. MYC regulates the antitumor immune response through CD47 and PD-L1. Sci. (New York N Y). 352, 227\u2013231. https:\/\/doi.org\/10.1126\/science.aac9935 (2016).","journal-title":"Sci. (New York N Y)"},{"key":"42801_CR37","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jtho.2024.03.019","volume":"19","author":"LY Hu","year":"2024","unstructured":"Hu, L. Y. et al. EGFR Oncogenic Mutations in NSCLC Impair Macrophage Phagocytosis and Mediate Innate Immune Evasion Through Up-Regulation of CD47. J. Thorac. oncology: official publication Int. Association Study Lung Cancer. 19, 1186\u20131200. https:\/\/doi.org\/10.1016\/j.jtho.2024.03.019 (2024).","journal-title":"J. Thorac. oncology: official publication Int. Association Study Lung Cancer"},{"key":"42801_CR38","doi-asserted-by":"publisher","first-page":"102540","DOI":"10.1016\/j.tranon.2025.102540","volume":"64","author":"T Guo","year":"2025","unstructured":"Guo, T. et al. GATAD2B promotes ovarian cancer malignant progression via MYC\/CD47 Axis. Translational Oncol. 64, 102540. https:\/\/doi.org\/10.1016\/j.tranon.2025.102540 (2025).","journal-title":"Translational Oncol."},{"key":"42801_CR39","doi-asserted-by":"publisher","first-page":"6308","DOI":"10.1038\/s41467-022-34064-4","volume":"13","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasion. Nat. Commun. 13, 6308. https:\/\/doi.org\/10.1038\/s41467-022-34064-4 (2022).","journal-title":"Nat. Commun."},{"key":"42801_CR40","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3389\/fonc.2020.01525","volume":"10","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. CD47 Enhances Cell Viability and Migration Ability but Inhibits Apoptosis in Endometrial Carcinoma Cells via the PI3K\/Akt\/mTOR Signaling Pathway. Front. Oncol. 10, 1525. https:\/\/doi.org\/10.3389\/fonc.2020.01525 (2020).","journal-title":"Front. Oncol."},{"key":"42801_CR41","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.7150\/ijbs.60782","volume":"17","author":"X Jia","year":"2021","unstructured":"Jia, X. et al. CD47\/SIRP\u03b1 pathway mediates cancer immune escape and immunotherapy. Int. J. Biol. Sci. 17, 3281\u20133287. https:\/\/doi.org\/10.7150\/ijbs.60782 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"42801_CR42","doi-asserted-by":"publisher","unstructured":"Ooki, A., Osumi, H., Shimozaki, K. & Yamaguchi, K. Novel immunotherapy for gastric cancer: targeting the CD47-SIRP\u03b1 axis. Cancer Metastasis Rev. 44 https:\/\/doi.org\/10.1007\/s10555-025-10269-z (2025).","DOI":"10.1007\/s10555-025-10269-z"},{"key":"42801_CR43","doi-asserted-by":"publisher","first-page":"e943","DOI":"10.1002\/ctm2.943","volume":"12","author":"R Bouwstra","year":"2022","unstructured":"Bouwstra, R., van Meerten, T. & Bremer, E. CD47-SIRP\u03b1 blocking-based immunotherapy: Current and prospective therapeutic strategies. Clin. translational Med. 12, e943. https:\/\/doi.org\/10.1002\/ctm2.943 (2022).","journal-title":"Clin. translational Med."},{"key":"42801_CR44","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1158\/0008-5472.Can-14-0037-t","volume":"74","author":"DR Soto-Pantoja","year":"2014","unstructured":"Soto-Pantoja, D. R. et al. CD47 in the tumor microenvironment limits cooperation between antitumor T-cell immunity and radiotherapy. Cancer Res. 74, 6771\u20136783. https:\/\/doi.org\/10.1158\/0008-5472.Can-14-0037-t (2014).","journal-title":"Cancer Res."},{"key":"42801_CR45","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3727\/096504017x14900505020895","volume":"25","author":"H Tao","year":"2017","unstructured":"Tao, H., Qian, P., Wang, F., Yu, H. & Guo, Y. Targeting CD47 Enhances the Efficacy of Anti-PD-1 and CTLA-4 in an Esophageal Squamous Cell Cancer Preclinical Model. Oncol. Res. 25, 1579\u20131587. https:\/\/doi.org\/10.3727\/096504017x14900505020895 (2017).","journal-title":"Oncol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42801-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42801-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42801-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T06:28:18Z","timestamp":1776666498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42801-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42801"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42801-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Research Ethics Committee of Daping Hospital of the Army Medical University. All the experiments were conducted in accordance with the guidelines of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Patients were asked to sign an informed consent before inclusion in the study. Written informed consent was obtained from the patient\/participant in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"12819"}}